Mumbai-based Glenmark has been issued a FDA warning letter for manufacturing issues.
Pfizer inks antisense drug deal worth up to $1.5B
Pfizer will front $250 million to gain rights to a phase 2 drug.
A jury has ordered J& to pay $8 billion for a claim that the company failed to warn patients.
Universities around the world have accepted at least $60 million in donations over the past five years.
A couple of deciding factors remain constant industry-wide